Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00992953 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality (VR) Therapy for Post-Traumatic Stress Disorder (PTSD)
A Phase 1 study of Post Traumatic Stress Disorder, sponsored by Office of Naval Research (ONR).
- Completed
- Registry status
- Phase 1
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT00992953 is a Phase 1 study of Post Traumatic Stress Disorder that has completed, run by Office of Naval Research (ONR). The registered enrollment target is 136 participants, below the 1,116-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00992953, a Phase 1 study of Post Traumatic Stress Disorder, has completed, sponsored by Office of Naval Research (ONR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
It is proposed that using Virtual Reality as part of therapy will result in improvements in Post Traumatic Stress Disorder for Service Members with PTSD related to service in Iraq and/or Afghanistan.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Virtual Reality Exposure with Stimulus Control
Study Locations (2)
California
- Naval Hosptial Camp Pendleton - Camp Pendlton
- Naval Medical Center San Diego (NMCSD) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00992953
The ClinicalTrials.gov registry entry for NCT00992953 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,116-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (88% lower). The listed sponsor is Office of Naval Research (ONR), which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT00992953 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00992953 about?
NCT00992953 is a clinical study titled "Virtual Reality (VR) Therapy for Post-Traumatic Stress Disorder (PTSD)". It is proposed that using Virtual Reality as part of therapy will result in improvements in Post Traumatic Stress Disorder for Service Members with PTSD related to service in Iraq and/or Afghanistan.
What is the current status of trial NCT00992953?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 136 participants. The study started on 2005-01. Estimated completion is 2009-10.
What conditions does trial NCT00992953 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00992953?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Virtual Reality Exposure with Stimulus Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT00992953?
This trial is sponsored by Office of Naval Research (ONR), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00992953 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
RECRUITING · Phase 1
-
A Study of Psilocybin for PTSD
ACTIVE NOT RECRUITING · Phase 1
-
Biological Signatures, Probiotic Among Those With mTBI and PTSD
COMPLETED · Phase 1
-
Cannabidiol as a Treatment for AUD Comorbid With PTSD
COMPLETED · Phase 1
-
Bringing What Works to Youth in Corrections: A Trauma Intervention
COMPLETED · Phase 1
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.